From May 1, 2023 to July 31, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,883,346 shares, representing 10.34% for $5.63 million under the buyback announced on February 2, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.11 USD | -0.47% | -0.47% | -2.31% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.31% | 17.84M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- PMCB Stock
- News PharmaCyte Biotech, Inc.
- Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on February 2, 2023.